Blood filtration stocks are on fire...!...since their March 2020 pandemic start, lows !
Here's a sampling:
CTSO March 2020 low $ 4.00. Currently $ 8.00 + 100%
Likely aided by their failed studies and lack of a US Trial (even Phase 1)
ohh..and trades on Nasdaq
AEMD March 2020 lo $ 1.28. Currenlty $ 2.14 + 67%
Likely aided by their 2 person non-trial results, and bantering around of ideas.
Ohh...and trades on Nasdaq
EDT March 2020 lows .44. Currently $ .46 + 4.5%
Likely aided by:
Phase 3 B confimatory Trial
FDA approval of SAMI for US
FDA approval of DIMI for hopspital use
Health Canada approval of DIMI
Hiring of Kellum (world KoL on blood filtration and AKI)
Baxter advancement of $ 15M + on Tigris Trial and DA
Ohh..and trades in Canada with limited to no news flow to the US.
MM